LLY Eli Lilly & Co
Performance
0.93% Past Week
Market Cap
319.42B
Day’s Range
52W Range
Volume (3M)
3.1M
Price-Earnings Ratio
49.43
Revenue
28.54B
Eli Lilly & Co Latest News



About Eli Lilly & Co
Eli Lilly & Co is an American pharmaceutical company based in Indianapolis, Indiana. It is engaged in the discovery and development of medications and healthcare solutions for an international customer base. Established in 1876, the company trades on the NYSE with the ticker LLY. Invest in this instrument here on eToro and stay updated on LLY value changes.
Show More39K
Employees
Indianapolis, Indiana, US
HQ
1876
Founded
David A. Ricks, MBA
CEO
Upcoming Earnings
27
APR
REPORTS
Eli Lilly & Co Q1 2023 earnings report is expected to be released before market open
Consensus
Moderate Buy
Price Target
386.25
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
60
High
Industry
Avg. 47
70
Environment
69
Social
49
Governance
People Also Bought
- MRK Merck & Co. 0.55%
- ABT Abbott Laboratories 1.04%
- TMO Thermo Fisher Scientific Inc 0.55%
- NOVO-B.CO Novo Nordisk B A/S 1.37%
- NVO Novo-Nordisk A/S SPONS ADR 2.12%
335.33